Company / Cash & Equivalents
UFP Technologies, Inc. Cash & Equivalents History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$20.3M
FY2025
5-year range
$4.5M / $20.3M
FY2021-FY2025
Trend
+50.9%
vs FY2024
Sector context
#150 of 152
Health Care
What the data says
Among 152 Health Care companies, UFP Technologies, Inc. is in the bottom 1% for cash & equivalents. Cash & Equivalents has increased for 3 consecutive years, from $4M in FY2022 to $20M in FY2025.
Based on SEC 10-K filings.
$20M in FY2025 with a 5-year CAGR of -3.5%.
Improved from $5M to $20M over the past 2 years.
Health Care sector context is included.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- +65.8%
- 5-Year CAGR
- -3.5%
- 10-Year CAGR
- -
Sector benchmark
Bottom 1% in Health CareTop 99% of 152This company $20.3M Sector average $1.2B
▼
-98.3% below sector average
Key checks
Key Insights
- UFP Technologies, Inc.'s cash & equivalents has grown for 3 consecutive years.
- 5-year CAGR of -3.5%, indicating a declining trend.
- In FY2025, cash & equivalents increased 50.9% year-over-year.
- Ranks #150 out of 152 companies in the Health Care sector.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Strong profit margin: 39.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $20.3M | +50.9% |
| FY2024 | $13.4M | +155.6% |
| FY2023 | $5.3M | +18.2% |
| FY2022 | $4.5M | -60.0% |
| FY2021 | $11.1M | -54.1% |
| FY2020 | $24.2M | +547.4% |
| FY2019 | $3.7M | +15.6% |
| FY2018 | $3.2M | -91.5% |
| FY2017 | $38.0M | +21.1% |
| FY2016 | $31.4M | +5.2% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026